Acupuncture for chronic prostatitis/ chronic pelvic pain syndrome

Nickel JC: Prostatitis and related conditions. In Campbell’s Urology, edn 8. Edited by Walsh PC, Retik AB, Vaughan ED Jr. Philadelphia: W.B. Saunders; 2002:603–630. Nickel JC: The three A’s of chronic prostatitis therapy: antibiotics, alpha-blockers, and anti-inflammatories: What is the evidence? BJU Int 2004, in press. Gun CC: Neuropathic pain: a new theory for chronic pain of intrinsic origin. Ann R Coll Physicians Surg Can 1989, 22:327–330. Yuting C: Clinical observation on combined treatment of 360 cases of prostatitis with acupuncture of Sishenchong Point and self-drafted prescription I, II and III. World J Acupunct Moxibustion 2000, 10:1–4. Katai S: Effect of electric acupuncture therapy on chronic prostatitis. Bull Juntendou Univ 1992, 38:210–219. Ikeuchi T, Iguchi H: Clinical studies on chronic prostatitis and prostatitis-like syndrome: electric acupuncture therapy for intractable cases of chronic prostatitis-like syndrome. Hinyokika Kiyo 1994, 40:587–591. Chen C, Gao Z, Liu Y, Shen L: Treatment of chronic prostatitis with laser acupuncture. J Tradit Chin Med 1995, 15:38–41. Ge SH, Mang FY, Xu BR: Acupuncture treatment in 102 cases of chronic prostatitis. J Tradit Chin Med 1988, 8:99–100. Chen RC, Nickel JC: Acupuncture ameliorates symptoms in men with chronic prostatitis and chronic pelvic pain syndrome. Adult Urol 2003, 61:1156–1159. Krieger JN, Nyberg L, Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 1999, 282:236–237. Litwin SM, McNaughton-Collins M, Fowler FJ, et al.: The NIH Chronic Prostatitis Symptom Index (NIH-CPSI): development and validation of a new outcomes measure. J Urol 1999, 162:369–375. Price DD, Mayer DJ: Evidence for endogenous opiate analgesic mechanism and triggers by somatosensory stimulation (include acupuncture) in humans. PAIS Forum 1995, 4:40–43. Stux G, Pomeranz B: Basics of Acupuncture, edn 4. New York: Springer; 1998. Cheng RS, Pomeranz B: Electroacupuncture analgesia could be medicated by at least two pain-relieving mechanisms: endorphin and nonendorphin system. Life Sci 1979, 25:1957–1962. Cheng RS: Dexamethasone partially reduces 2% saline abolishes electro acupuncture analgesic, and these finding implicate pituitary endorphin. Life SCT 1979, 24:1481–1486. Cheng RS: Mechanism of electro acupuncture analgesic on intricate system is proposed. In PhD Thesis. Toronto: University of Toronto; 1981. Helms JM: Chapter II. In Acupuncture Energetics and Clinical Approach for Physicians. California: Medical Acupuncture Publisher; 1995: 31–36. De Groot WC: Anatomy of the central neural pathways controlling the lower urinary tract. Eur Urol 1998, 34(suppl 1):2–5. Han JS, Tereniu H: Neurochemical basis of acupuncture analgesic. Annu Rev Pharmacol Toxicol 1982, 22:193–200. Vacca-Galloway LL, Naftchi NE, Arakawa K, et al.: Alteration of immunoreactive substance P and enkephalin in rate spinal cord after electroacupuncture. Peptides 1985, 6(suppl 1):177–188. Chang RS, Pomeranz B: A combined treatment with D-amino acids and electroacupuncture produces a greater analgesia then either treatment alone: naloxone reverses these effects. Pain 1980, 8:231–236. Mezey E, Palkovits M, de Kloet ER, et al.: Evidence for pituitary-brain transport of a behaviorally potent ACTH analog. Life Sci 1978, 22:831–838. Bergland RM, Page RB: Pituitary-brain vascular relations: a new paradigm. Science 1979, 204:18–24. Tsou K, Wu SH, Wan FS, et al.: Increased levels of endorphins in the cisteral cerebrospinal fluid of rabbits in acupuncture analgesia. Act Physiologic Sinica 1979, 31:371–376. Zermann DH, Ishigooka M, Schmidt R: Pathophysiology of the hypertonic sphincter or hyperpathic urethra. In The Urinary Sphincter. Edited by Corcos J, Schick E. New York: Marcel Dekker; 2001:201–205. This article is instructive and comprehensive. It supports the hypothesis that neuromodulatory treatments for CP/CPPS could be beneficial. Zhang ZY, Zhang K: Effect of acupuncture on the pons micturition centre and the related function of the urinary bladder. Zhen Ci Yan Jiu 1987, 12:116–122. Pomeranz B, Cheng R: Suppression of noxious responses in single neurons of cat spinal cord by electroacupuncture and its reversal by the opiate antagonist naloxone. Exp Neurol 1979, 64:327–341. Basbaum AI, Fields HL: Endogenous pain control mechanism: review and hypothesis. Ann Neurol 1978, 4:451–462. Yaksh TL, Wilson PR: Spinal serotonin terminal system medicates antinociception. J Pharmacol Exp Ther 1979, 208:446–453. Rosenfeld JP: Interacting brain stem components of opiateactivated descending pain inhibitory system. Neurosci Biobehav Rev 1994, 18:403–409. Yi CC, Lu TH, Wu SH, Tsou K: A study of the release of H (37 S-Hydroxytryptamine from brain during acupuncture and morphine analgesia. Sci Sin 1977, 20:113–124. Han CS, Shou PH, Lu CC, et al.: The role of central S-hydroxytryptamine in acupuncture analgesia. Sci Sin 1979, 22:91–104. Espey MJ, Du HJ, Downie JW: Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats. Brain Res 1988, 798:101–108. Dmochowski RR, Miklos JR, Norton PA, et al.: Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 2003, 170:1259–1263. Thor KB: Neurology: exploring new horizons and advanced studies. John Hopkins Med J 2002, 2:677–680. Shoskes DA, Albakri Q, Thomas K, Cook D: Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol 2002, 168:331–335. This article postulates a hypothesis that men with CP/CPPS may have a genetic predisposition to inflammation or autoimmunity. Schmidt RA: Pelvic pain. Prob Urol 1989, 3:270–280. Codeere TJ, Katz J, Vaccarino A, Melzack R: Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993, 52:259–285.